Results of a study Sabinsa's Curcumin C3 Complex.
Curcumin may be an effective ingredient for lowering triglycerides, according to a study published in Phytotherapy Research.
High lipid content in blood serum is considered a risk factor for heart disease, and it is also a common feature of obesity. Previous research has supported curcumin, a principle compound from turmeric, for reducing triglycerides.
For one month, Iranian researchers assigned 30 obese subjects to a daily dose of placebo or 1 g of Curcumin C3 Complex, a unique composition of curcuminoids and bioavailability-enhancing BioPerine piperine extract from Sabinsa Corp. (East Windsor, NJ). Researchers routinely assessed weight parameters, cholesterol levels, and C-reactive protein levels in each subject.
While curcumin supplementation did not appear to affect cholesterol or C-reactive protein, it did significantly lower triglyceride levels for both crossover groups: from 105.7 to 95.1 mg/dL and 120.7 to 104.7 mg/dL.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.